SCHEMBL23625284

SCHEMBL23625284

CCCC(C)c1ccc(Nc2ccc(C(C)C)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFKB1 P19838 2/20 0.44
▸ POLB P06746 2/20 0.44
▸ SMN1; SMN2 Q16637 5/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ RAB9A P51151 5/20 0.41
▸ HPGD P15428 4/20 0.41
▸ NPC1 O15118 4/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ EPHX1 P07099 1/20 0.40
▸ CRHBP P24387 1/20 0.37
▸ CRHR2 Q13324 1/20 0.37
▸ SRC P12931 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24564510 0.87 HPGD (0.45) SMN1; SMN2ALDH1A1RAB9AHPGDNPC1
SCHEMBL29950147 0.81 NFKB1 (0.59) NFKB1POLBSMN1; SMN2ALDH1A1RAB9A
SCHEMBL3958499 0.81 NFKB1 (0.59) NFKB1POLBSMN1; SMN2ALDH1A1RAB9A
SCHEMBL9746668 0.81 RIPK1 (0.43) SMN1; SMN2
Benzene SCHEMBL28222709 0.77 NFKB1 (0.55) NFKB1POLBSMN1; SMN2ALDH1A1RAB9A
SCHEMBL24106999 0.76 BCHE (0.39) NFKB1POLBSMN1; SMN2ALDH1A1RAB9A
SCHEMBL3005259 0.76 NFKB1 (0.47) NFKB1POLBSMN1; SMN2ALDH1A1RAB9A
SCHEMBL20758394 0.75 GRIA4 (0.42) ALDH1A1HPGDL3MBTL1TSHRTDP1
SCHEMBL2407454 0.75 GRIA4 (0.42) ALDH1A1HPGDL3MBTL1TSHRTDP1
SCHEMBL10274563 0.75 ADRB2 (0.48) SMN1; SMN2HPGDTSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210206791-A1 SELECTIVE METAL-MEDIATED ARYLATION OF DICHALCOGENIDES IN BIOMOLECULES MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2021-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210206791-A1 SELECTIVE METAL-MEDIATED ARYLATION OF DICHALCOGENIDES IN BIOMOLECULES SCLY, SELENOI, PTMS NFKB1 4869/4885POLB 3413/4885SMN1; SMN2 3246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback